| Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression C Gabellini, D Trisciuoglio, M Desideri, A Candiloro, Y Ragazzoni, ... European journal of cancer 45 (14), 2618-2627, 2009 | 181 | 2009 |
| Toll-like receptor 3 regulates angiogenesis and apoptosis in prostate cancer cell lines through hypoxia-inducible factor 1α A Paone, R Galli, C Gabellini, D Lukashev, D Starace, A Gorlach, ... Neoplasia 12 (7), 539-549, 2010 | 112 | 2010 |
| Bcl-2 regulates HIF-1α protein stabilization in hypoxic melanoma cells via the molecular chaperone HSP90 D Trisciuoglio, C Gabellini, M Desideri, E Ziparo, G Zupi, D Del Bufalo PLoS One 5 (7), e11772, 2010 | 110 | 2010 |
| Bcl-2 regulates HIF-1α protein stabilization in hypoxic melanoma cells via the molecular chaperone HSP90 D Trisciuoglio, C Gabellini, M Desideri, E Ziparo, G Zupi, D Del Bufalo PLoS One 5 (7), e11772, 2010 | 107 | 2010 |
| α‐tocopherol protects against cisplatin‐induced toxicity without interfering with antitumor efficacy C Leonetti, A Biroccio, C Gabellini, M Scarsella, V Maresca, E Flori, ... International journal of cancer 104 (2), 243-250, 2003 | 100 | 2003 |
| BCL-XL overexpression promotes tumor progression-associated properties D Trisciuoglio, MG Tupone, M Desideri, M Di Martile, C Gabellini, ... Cell death & disease 8 (12), 3216, 2017 | 98 | 2017 |
| SETD5 regulates chromatin methylation state and preserves global transcriptional fidelity during brain development and neuronal wiring A Sessa, L Fagnocchi, G Mastrototaro, L Massimino, M Zaghi, M Indrigo, ... Neuron 104 (2), 271-289. e13, 2019 | 95 | 2019 |
| c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells A Biroccio, B Benassi, S Amodei, C Gabellini, D Del Bufalo, G Zupi Molecular Pharmacology 60 (1), 174-182, 2001 | 91 | 2001 |
| 1, 4-Dihydropyridines active on the SIRT1/AMPK pathway ameliorate skin repair and mitochondrial function and exhibit inhibition of proliferation in cancer cells S Valente, P Mellini, F Spallotta, V Carafa, A Nebbioso, L Polletta, ... Journal of Medicinal Chemistry 59 (4), 1471-1491, 2016 | 75 | 2016 |
| Involvement of BH4 domain of bcl-2 in the regulation of HIF-1-mediated VEGF expression in hypoxic tumor cells D Trisciuoglio, C Gabellini, M Desideri, Y Ragazzoni, T De Luca, E Ziparo, ... Cell Death & Differentiation 18 (6), 1024-1035, 2011 | 68 | 2011 |
| CPTH6, a thiazole derivative, induces histone hypoacetylation and apoptosis in human leukemia cells D Trisciuoglio, Y Ragazzoni, A Pelosi, M Desideri, S Carradori, ... Clinical cancer research 18 (2), 475-486, 2012 | 63 | 2012 |
| Involvement of RB gene family in tumor angiogenesis C Gabellini, D Del Bufalo, G Zupi Oncogene 25 (38), 5326-5332, 2006 | 63 | 2006 |
| Involvement of RB gene family in tumor angiogenesis C Gabellini, D Del Bufalo, G Zupi Oncogene 25 (38), 5326-5332, 2006 | 63 | 2006 |
| Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer D Del Bufalo, M Desideri, T De Luca, M Di Martile, C Gabellini, V Monica, ... Molecular cancer 13, 1-16, 2014 | 60 | 2014 |
| Interleukin 8 mediates bcl‐xL‐induced enhancement of human melanoma cell dissemination and angiogenesis in a zebrafish xenograft model C Gabellini, E Gómez‐Abenza, S Ibáñez‐Molero, MG Tupone, ... International journal of cancer 142 (3), 584-596, 2018 | 58 | 2018 |
| Modulation of bcl-xL in tumor cells regulates angiogenesis through CXCL8 expression S Giorgini, D Trisciuoglio, C Gabellini, M Desideri, L Castellini, ... Molecular cancer research 5 (8), 761-771, 2007 | 57 | 2007 |
| Non-canonical roles of Bcl-2 and Bcl-xL proteins: relevance of BH4 domain C Gabellini, D Trisciuoglio, D Del Bufalo Carcinogenesis 38 (6), 579-587, 2017 | 54 | 2017 |
| Involvement of nuclear factor‐kappa B in bcl‐xL‐induced interleukin 8 expression in glioblastoma C Gabellini, L Castellini, D Trisciuoglio, M Kracht, G Zupi, D Del Bufalo Journal of neurochemistry 107 (3), 871-882, 2008 | 54 | 2008 |
| Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells M Di Martile, M Desideri, T De Luca, C Gabellini, S Buglioni, A Eramo, ... Oncotarget 7 (10), 11332, 2016 | 50 | 2016 |
| Telomere dysfunction increases cisplatin and ecteinascidin-743 sensitivity of melanoma cells A Biroccio, C Gabellini, S Amodei, B Benassi, D Del Bufalo, R Elli, ... Molecular pharmacology 63 (3), 632-638, 2003 | 46 | 2003 |
Ruggero De MariaInstitute of General Pathology, Catholic University, RomeVerified email at unicatt.it
